Gruppo Italiano Malattie Ematologiche Dell'adulto

This study will observe 93 adults with myelofibrosis who are starting momelotinib as part of their normal care. Researchers want to see how well the drug reduces an enlarged spleen after 6 months. The goal is to understand the drug's real-world effectiveness beyond clinical trial…

This study checks if a new, highly sensitive DNA test (digital PCR) can find gene mutations in adults with chronic myeloid leukemia (CML) whose current treatment is not working. Researchers will compare this test to the standard genetic test to see if it is just as good at spotti…

This study will track infection rates and patterns in 50 adults with relapsed/refractory multiple myeloma who are receiving elranatamab as part of their standard care. Participants must have tried at least three prior treatments. The goal is to gather safety information, not to t…

This study reviews medical records of about 103 adults with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who received the drug ponatinib as their first treatment in regular medical practice. Researchers want to see how many patients achieve a deep level of cancer …